Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)

NCT ID: NCT01054690

Last Updated: 2010-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

511 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a single blinded (Outcome Assessors), multicenter randomized controlled study designed to investigate if a silver alloyed urinary catheter with antibacterial properties can reduce the incidence of catheter acquired urinary tract infections in patients undergoing elective surgery. Patients requiring urinary catheterization will be randomized into two groups and receive either the silver alloyed catheter (test) or a silicone catheter (control).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Silver alloyed urinary catheter

Group Type EXPERIMENTAL

Bactiguard Infection Protection (BIP) Cathter.

Intervention Type DEVICE

Silicone urinary catheter

Group Type PLACEBO_COMPARATOR

Silicone Urinary Catheter

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bactiguard Infection Protection (BIP) Cathter.

Intervention Type DEVICE

Silicone Urinary Catheter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults in elective surgery requiring urinary catheterization

Exclusion Criteria

* Patients who has or recently (within 3 weeks) had a urinary catheter
* Signs of urinary tracts infection
* Previous radiation therapy in lower pelvis
* Latex allergy
* Cognitive impaired
* Do not understand Swedish language.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bactiguard AB, Sweden

UNKNOWN

Sponsor Role collaborator

Region Skane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Urology, University Hospital in Lund

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karin Stenzelius, PhD Nurse

Role: PRINCIPAL_INVESTIGATOR

Department Urology, University Hospital in Lund, Sweden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ortopedkliniken, Hässleholms Sjukhus

Hässleholm, , Sweden

Site Status

Ortopedklinien, Lunds Hospital

Lund, , Sweden

Site Status

Ortopedkliniken Lasarettet i Trelleborg

Trelleborg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H15 315/2007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Midlines and Thrombophlebitis
NCT03725293 COMPLETED NA